Skip to main content
Top

Drugs

Issue 10/2016

Content (9 Articles)

Fimasartan: A New Angiotensin Receptor Blocker

  • Review Article

Hae-Young Lee, Byung-Hee Oh

Secukinumab: A Review in Ankylosing Spondylitis

  • Adis Drug Evaluation

Hannah A. Blair, Sohita Dhillon

Rotigotine Transdermal Patch: A Review in Restless Legs Syndrome

  • Adis Drug Evaluation

Karly P. Garnock-Jones

Sugammadex: A Review of Neuromuscular Blockade Reversal

  • Adis Drug Evaluation

Gillian M. Keating

Pimavanserin: First Global Approval

  • AdisInsight Report

Anthony Markham

Comment on ‘What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain: Expert Opinion’

  • Letter to the Editor

Raffaele Giusti, Lucilla Verna, Daniela Iacono, Agnese Vannini, Corrado Ficorella, Giampiero Porzio

Reply—Letter to the Editor: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion

  • Open Access
  • Letter to the Editor

R. Vellucci, G. Fanelli, P. A. Cortesi, R. Pannuti, C. Peruselli, P. Romualdi

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images